恒瑞医药(600276)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600276 恒瑞医药

已收盘 01-14 15:00:00

{"stockData":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"恒瑞医药","latestPrice":63.61,"timestamp":1768374000000,"preClose":64.52,"halted":0,"volume":62925534,"delay":0,"changeRate":-0.0141,"floatShares":6379000000,"shares":6637000000,"eps":1.1252,"marketStatus":"已收盘","change":-0.91,"latestTime":"01-14 15:00:00","open":64.55,"high":65.6,"low":63.2,"amount":4049000000,"amplitude":0.0372,"askPrice":63.61,"askSize":195482,"bidPrice":63.6,"bidSize":160,"shortable":0,"etf":0,"ttmEps":1.1252,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768440600000},"marketStatusCode":5,"adr":0,"adjPreClose":64.52,"symbolType":"stock","openAndCloseTimeList":[[1768354200000,1768361400000],[1768366800000,1768374000000]],"highLimit":70.97,"lowLimit":58.07,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":6637199874,"isCdr":false,"pbRate":7.1,"roa":"--","peRate":56.532172,"roe":"11.09%","epsLYR":1,"committee":-0.994767,"marketValue":422192000000,"turnoverRate":0.0099,"status":1,"hkstockBrief":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"恒瑞医药","latestPrice":79.1,"timestamp":1768378086006,"preClose":78.7,"halted":0,"volume":4224192,"delay":0,"premium":"+11.16"},"floatMarketCap":405768000000},"requestUrl":"/m/hq/s/600276","defaultTab":"news","newsList":[{"id":"2603769682","title":"雅本化学：公司与恒瑞医药的合作模式为CDMO模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2603769682","media":"证券日报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603769682?lang=zh_cn&edition=full","pubTime":"2026-01-13 21:38","pubTimestamp":1768311484,"startTime":"0","endTime":"0","summary":"证券日报网讯1月13日，雅本化学在互动平台回答投资者提问时表示，公司与恒瑞医药的合作模式为CDMO模式，覆盖恒瑞医药从临床前到商业化生产的各个阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601133617688110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0359201885.HKD","LU2097828474.EUR","01276","BK0188","LU1997245094.SGD","BK0196","LU2580892789.USD","LU2289578879.USD","LU0405327494.USD","LU1997244956.HKD","LU1255011170.USD","LU2495084118.USD","600276","LU2328871848.SGD","LU1655091616.SGD","LU1997245177.USD","LU1146622755.USD","LU2543165471.USD","BK0012","LU0405327148.USD","LU1328615791.USD","BK0229","BK4139","LU0359202008.SGD","LU2097828631.EUR","LU1064131003.USD","LU2097828805.USD","BK0060","BK0174","LU2097828557.USD","LU2148510915.USD","LU1023057109.AUD","BK0028","LU1064130708.USD","300261","LU1820825898.SGD","LU1969619763.USD","BK0183","LU2097828714.EUR","LU2580892862.HKD","LU2488822045.USD","LU0359201612.USD","LU1580142542.USD","BK1191","BK0239","LU1781817850.SGD","CDMO"],"gpt_icon":0},{"id":"2603668676","title":"GLP-1价格风暴：礼来2折“甩卖”替尔泊肽，国产药未上市先承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2603668676","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603668676?lang=zh_cn&edition=full","pubTime":"2026-01-13 20:02","pubTimestamp":1768305720,"startTime":"0","endTime":"0","summary":"2025年末至2026年初，国内GLP-1（胰高血糖素样肽-1）领域掀起一场颠覆性的价格风暴。随着礼来旗下核心产品替尔泊肽注射液（商品名：穆峰达）成功纳入国家医保目录，2型糖尿病每月治疗费用最低降至324．1元，较上市初期对应规格的月均2000元降幅超80%。近乎“两折”的医保定价让这款“全球药王”产品彻底走下高价神坛，竞争对手诺和诺德被迫跟进调价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601133617616496.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601133617616496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0417517546.SGD","LU2237443382.USD","IE00BJJMRX11.SGD","LU2237443622.USD","LU0471298777.SGD","LU0823416689.USD","LU2112291526.USD","IE0005OL40V9.USD","LU0114720955.EUR","LU2089984988.USD","SG9999001176.USD","LU0471298694.HKD","LU1989771016.USD","LU1868836914.USD","LU2471134523.USD","LU0122379950.USD","SG9999018857.SGD","LU0094547139.USD","LU1917777945.USD","SG9999014880.SGD","SG9999017495.SGD","SGXZ99366536.SGD","LU2456880835.USD","LU2265009873.SGD","LU2237443549.SGD","LU1720051017.SGD","BK4534","LU0256863902.USD","GB00BDT5M118.USD","SG9999001176.SGD","IE00BJLML261.HKD","LU0109394709.USD","LU1804176565.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU0889565916.HKD","LU0109391861.USD","SGXZ31699556.SGD","LU0786609619.USD","LU1323610961.USD","LU2491049909.HKD","LU1093756325.SGD","LU1868836757.USD","LU2750360997.AUD","BK4590","LU2108987350.USD","LU2237443895.HKD","BK4144","LU0256863811.USD","LU0882574139.USD","LU2746668461.USD","LU0079474960.USD","LU2168564149.EUR","LU1232071149.USD","IE0002141913.USD","SG9999015952.SGD","LLY","SGXZ57979304.SGD","BK4533","LU2491050071.SGD","LU2168564495.EUR","LU0640476718.USD","IE00B4JS1V06.HKD","BK4516","IE00BJJMRY28.SGD","LU0097036916.USD","SGXZ81514606.USD","LU1061106388.HKD","LU0203201768.USD","LU0689472784.USD","LU1064131342.USD","IE00B1BXHZ80.USD","LU0096364046.USD","LU1093756168.USD","BK4599","LU1623119135.USD","LU1814569148.SGD","LU1551013425.SGD","LU2087625088.SGD","LU2168564065.EUR","LU1868837136.USD","LU0058720904.USD","LU0353189680.USD","LU0943347566.SGD","LU2471134796.USD","SG9999018865.SGD","LU0354030511.USD","IE00BK4W5L77.USD","LU2237438978.USD","LU0203202063.USD","LU0385154629.USD","LU1548497426.USD","LU0320765992.SGD","IE00BJJMRZ35.SGD","LU2471134952.CNY","LU2552382132.HKD","BK4585","LU1868836591.USD","LU0353189763.USD","IE00B1XK9C88.USD","LU2023250504.SGD","LU0106261372.USD","LU1267930730.SGD","LU0466842654.USD","LU2471134879.HKD","LU2168563687.JPY","LU0823434583.USD","LU1280957306.USD","IE00BKDWB100.SGD","LU1366192091.USD","LU0225283273.USD","IE00B4R5TH58.HKD","LU0316494557.USD","LU2746668974.SGD","SG9999014914.USD","LU0061475181.USD","LU0289739699.SGD","LU1069344957.HKD","LU1868837300.USD","LU2211815571.USD","SG9999015945.SGD","LU0456855351.SGD","LU2324357040.USD","LU1023059063.AUD","IE00BFSS8Q28.SGD","LU0238689110.USD","LU2491050154.USD","LU2236285917.USD","600276","IE00BFTCPJ56.SGD","LU2237443465.HKD","LU0787776722.HKD","IE0004445015.USD","BK4007","LU2357305700.SGD","IE0009355771.USD","LU1035775433.USD","SG9999015986.USD","LU2264538146.SGD","LU0234572021.USD","LU2360106947.USD","01276","LU0820561909.HKD","LU2237443978.SGD","LU0323591593.USD","LU0198837287.USD","LU1988902786.USD","LU1057294990.SGD","LU0006306889.USD","LU2361045086.USD","IE00B7KXQ091.USD","SGXZ51526630.SGD","LU0820561818.USD","BK4588","IE00BK4W5M84.HKD","LU1551013342.USD","BK4581","IE00BN29S564.USD","LU0882574055.USD","SG9999013999.USD","IE00BFSS7M15.SGD","LU1127390331.HKD","LU1720051108.HKD","LU2462157665.USD","LU0432979614.USD","LU2361044949.HKD","LU2417539215.USD","SG9999014898.SGD","LU2168564222.USD","LU0672654240.SGD","SG9999014906.USD","LU1712237335.SGD","IE0004445239.USD","LU2461242641.AUD","IE00BJT1NW94.SGD","LU1291159041.SGD","LU2063271972.USD","LU2106854487.HKD","IE00BKPKM429.USD","LU0823434740.USD","SG9999015978.USD","LU1974910355.USD","LU0266013472.USD","LU2361044865.SGD","IE00BWXC8680.SGD","LU2750360641.GBP","LU1983299246.USD","LU2552382215.SGD","LU0708995401.HKD","IE00B775H168.HKD","LU2602419157.SGD","LU0320765059.SGD","LU0683600562.USD","LU0354030438.USD","LU2552382058.USD"],"gpt_icon":1},{"id":"2603550770","title":"岁末年初，药企高管缘何密集迎人事变动？","url":"https://stock-news.laohu8.com/highlight/detail?id=2603550770","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603550770?lang=zh_cn&edition=full","pubTime":"2026-01-13 18:00","pubTimestamp":1768298423,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者韩利明离职恒瑞医药（600276.SH）四年多后，周云曙的新任职动态浮出水面。日前，“江苏省肿瘤医院官方平台”发布消息显示，江苏省肿瘤医院（南京医科大学附属肿瘤医院）“江苏省恶性肿瘤先进诊疗重点实验室”与先声药业“神经与肿瘤药物研发全国重点实验室”正式签署战略合作协议，周云曙以“先声药业集团总裁”身份出席。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601133617514380.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601133617514380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0060","LU1064130708.USD","BK0183","LU2148510915.USD","BK0028","LU1655091616.SGD","BK1191","LU2580892862.HKD","600276","01276","LU0359202008.SGD","LU2488822045.USD","LU1023057109.AUD","LU0359201885.HKD","02096","LU2289578879.USD","LU0405327148.USD","LU0405327494.USD","LU1781817850.SGD","LU2495084118.USD","ADC","BK0188","BK0012","BK1583","LU1580142542.USD","LU1820825898.SGD","BK4231","LU2097828805.USD","LU2097828631.EUR","LU2097828474.EUR","LU2328871848.SGD","LU2543165471.USD","LU2097828557.USD","LU1146622755.USD","LU2580892789.USD","LU1328615791.USD","06978","LU1997245177.USD","LU1255011170.USD","LU1997245094.SGD","BK0239","BK4080","BK0196","LU2097828714.EUR","LU1969619763.USD","LU1997244956.HKD","LU1064131003.USD","BK1161","LU0359201612.USD","BK1574"],"gpt_icon":0},{"id":"2603506092","title":"智通AH统计|1月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2603506092","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603506092?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:15","pubTimestamp":1768292106,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止1月13日收盘，东北电气、浙江世宝、南京熊猫电子股份分列AH溢价率前三位，溢价率分别为800.00%、448.68%、279.68%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-12.21%、-2.14%、-1.80%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392172.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0034224299.USD","LU0516422440.USD","LU0106959298.USD","LU0228367735.SGD","LU0456854461.SGD","00042","LU0737861772.HKD","LU0791591158.USD","BK1505","IE00BZ08YT58.USD","LU2226246903.HKD","LU1008478684.HKD","LU1282649141.HKD","LU0307460666.USD","BK1135","LU0173614495.USD","IE00BZ08YS42.EUR","BK1576","IE00B3M56506.USD","IE00BZ08YR35.GBP","BK1223","LU2476274308.USD","IE00BGHQDM52.EUR","LU0328353924.USD","BK1149","LU1224709979.USD","LU1226287529.USD","LU1282648689.USD","BK1563","LU1481107354.HKD","BK1163","BK1183","IE00BYV24P56.USD","LU0463099449.HKD","IE00B5MMRT66.SGD","LU0488056044.USD","00553","02691","HK0000306701.USD","SG9999002463.SGD","LU0456846285.SGD","LU0455707207.USD","LU0348788117.USD","BK1141","LU0871576103.HKD","BK1526","LU0469268626.HKD","BK1237","LU0211977185.USD","BK1170","LU0648948544.HKD","LU0540923850.HKD","BK1610","LU0640798160.USD","BK1583","LU0823426480.USD","IE0008369823.USD","IE00B031J352.USD","LU0531971595.HKD","LU0918141705.HKD","LU1115378108.SGD","LU1242518857.USD","BK1116","LU1880383440.USD","LU0348805143.USD","LU0862451753.SGD","LU1023057109.AUD","LU0828237510.HKD","BK1544","LU1961090484.USD","LU0417516902.SGD","LU2097828805.USD","CIHKY","600775","LU0039217434.USD","LU0287142896.SGD","LU1188198961.HKD","LU0516423174.USD","01812","BK1144","600036","BK1592","LU1675838814.USD","600276","BK1147","LU0348825331.USD","LU1048596156.SGD","LU0051755006.USD","LU0918141887.USD","LU0823426308.USD","LU1282649810.SGD","LU1831875114.USD","BK1221","LU0329678337.USD","BK1551","LU0502904849.HKD","HK0000352291.HKD","LU0320764599.SGD","LU1993786604.SGD","LU1504937902.USD","IE00B29SXG58.USD","BK1501","LU0049853897.USD","LU2399975544.HKD","LU0979878070.USD","LU1688375341.USD","LU1720050803.USD","LU1808992512.USD","SG9999002828.SGD","LU0269904917.USD","LU0052750758.USD","IE0031814852.USD","LU0359201885.HKD","LU1770034418.SGD","01276","LU2476274720.SGD","BK1148","IE00B543WZ88.USD","LU0314109678.HKD","LU2045819591.USD","BK1546","BK1214","LU0384037296.USD","IE0008368742.USD","LU0067412154.USD","LU0348827113.USD","IE00BVYPNP33.GBP","LU0359201612.USD","LU0797268264.HKD","LU1328277881.USD","LU1769817096.USD","BK1205","LU0164865239.USD","LU1251922891.USD","LU2097828474.EUR","BK1513","IE00BMCWC346.EUR","002202","03143","BK1503","HK0000320223.HKD","03750","LU0417516738.SGD","LU0828238088.HKD","BK1558","LU0140636845.USD","BK1202","LU0329678170.USD","BK1562","LU0572944931.SGD","LU2125910500.SGD","BK1522","LU0821914370.USD","LU1960683339.HKD","LU1152091168.USD","LU1152091754.HKD","LU0972618739.USD","LU0828237940.HKD","HK0000306685.HKD","LU0228659784.USD","BK1171","IE00BF5LJ272.USD","LU0886674414.USD","BK1516","LU0737861699.HKD","BK1521","LU0456827905.SGD","IE00B0169L03.USD","LU0327786744.USD","LU0348814723.USD","LU1366334651.USD","LU0516422366.SGD","LU0561508036.HKD","BK1564","LU2778985437.USD","LU0348735423.USD","LU1655091616.SGD","LU1282649067.USD","BK1560","300750","BK1231","LU0163747925.USD","LU0149721374.USD","LU0431992006.USD","LU0048580855.USD","IE00B031HY20.USD","LU0096374516.USD","LU2543165471.USD","01057","LU0231483743.USD","LU0315179316.USD","LU0516423091.SGD","LU0791590937.USD","LU2242644610.SGD","LU1813983027.USD","LU0326950275.SGD","LU0181495838.USD","SG9999006597.SGD","LU2097828557.USD","LU0164880469.USD","LU0588546209.SGD","LU0501845795.SGD","LU1211504680.USD","LU1242518931.SGD","399300","LU1105468828.SGD","LU1807302812.USD","LU1769817179.HKD","BK1105","159982","LU0509642566.USD","LU1366334578.USD","LU0345780281.USD","000488","BK1554","LU0345780521.USD","BK1198","LU1046422090.SGD","BK1191","BK1514","BK1594","03968","BK1507","LU2097828631.EUR","HK0000352382.USD","LU2039709279.SGD","LU0348816934.USD","LU1794554557.SGD","IE00BVYPNQ40.USD","LU0117841782.USD","LU0229945570.USD","LU0880133367.SGD","LU0708995583.HKD","002703","LU0359202008.SGD","LU1303224171.USD","LU0061477393.USD","LU0593848301.USD","LU0589944569.HKD","LU1719994722.HKD","LU0890818403.SGD","LU2097828714.EUR","LU1880383366.USD","LU0543330566.HKD","LU0244354667.USD","LU0266512127.USD","LU0516422952.EUR","LU0868486357.SGD","SG9999004220.SGD","HK0000320264.USD","SG9999014674.SGD","LU0634319403.HKD","LU1785774172.SGD","LU0106252389.USD","LU0266512473.USD","LU0072913022.USD","LU0370786039.SGD","BK1509"],"gpt_icon":1},{"id":"2602498075","title":"恒瑞医药(01276)： HRS-7535 片拟用于高血压合并超重或肥胖治疗获批开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2602498075","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602498075?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:45","pubTimestamp":1768229113,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药 公布，近日，公司子公司山东盛迪医药有限公司收到国家药品监督管理局核准签发关于 HRS-7535 片的《药物临床试验批准通知书》，将于近期开展临床试验。根据《中华人民共和国药品管理法》及有关规定，经审查，2025 年 10 月 27 日受理的 HRS-7535 片符合药品注册的有关要求，同意本品开展临床试验。截至目前，HRS-7535 片相关项目累计研发投入约 36,940 万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1146622755.USD","LU1820825898.SGD","LU0405327494.USD","BK0060","BK0188","LU2097828474.EUR","LU2543165471.USD","LU1255011170.USD","LU1064131003.USD","LU2289578879.USD","BK0196","LU1781817850.SGD","LU0359201885.HKD","LU2097828714.EUR","LU0359202008.SGD","01276","LU2328871848.SGD","LU0405327148.USD","LU2580892862.HKD","LU2097828805.USD","BK0183","LU0359201612.USD","LU2495084118.USD","LU1969619763.USD","BK0028","LU2097828631.EUR","BK0239","BK0012","LU1023057109.AUD","BK1191","LU2097828557.USD","LU1997245177.USD","LU1064130708.USD","LU1997244956.HKD","LU1997245094.SGD","LU1580142542.USD","LU1655091616.SGD","LU2148510915.USD","600276","LU2488822045.USD","LU1328615791.USD","LU2580892789.USD"],"gpt_icon":0},{"id":"2602925995","title":"智通AH统计|1月12日","url":"https://stock-news.laohu8.com/highlight/detail?id=2602925995","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602925995?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:15","pubTimestamp":1768205705,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止1月12日收盘，东北电气、浙江世宝、南京熊猫电子股份分列AH溢价率前三位，溢价率分别为770.97%、432.48%、288.23%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-12.93%、-2.18%、-0.61%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0737861772.HKD","BK1141","HK0000306685.HKD","LU1211504680.USD","LU1282649141.HKD","LU1808992512.USD","LU1880383440.USD","SG9999012736.USD","LU1993786604.SGD","LU0455707207.USD","BK1198","BK1560","BK1584","BK1554","LU0821914370.USD","LU0431992006.USD","CIHKY","LU0052750758.USD","LU0164880469.USD","LU0862451753.SGD","LU0370786039.SGD","LU0140636845.USD","LU0244354667.USD","LU0359202008.SGD","LU1961090484.USD","LU2097828631.EUR","600775","LU0640798160.USD","LU1188198961.HKD","LU1046422090.SGD","SG9999012710.SGD","LU1366334651.USD","LU0589944569.HKD","LU1504937902.USD","LU2097828714.EUR","000488","LU0231483743.USD","LU0307460666.USD","BK1521","LU1115378108.SGD","HK0000352382.USD","LU0918141887.USD","BK1105","IE00B3M56506.USD","LU0049853897.USD","LU0791590937.USD","LU0287142896.SGD","IE00B031HY20.USD","LU0828237510.HKD","LU1688375341.USD","BK1149","LU0572939691.SGD","LU1960683339.HKD","LU0348814723.USD","LU0417516738.SGD","LU0106959298.USD","LU0348788117.USD","SG9999002828.SGD","LU0868486357.SGD","LU0890818403.SGD","600036","LU0463099449.HKD","LU1366334578.USD","LU0502904849.HKD","BK1564","LU2242644610.SGD","BK1513","LU1251922891.USD","LU0348805143.USD","03968","LU0348816934.USD","LU0634319403.HKD","LU0320764599.SGD","LU2226246903.HKD","LU1242518857.USD","LU0561508036.HKD","LU2125910500.SGD","LU0516423174.USD","LU2476274308.USD","LU1242518931.SGD","SG9999002463.SGD","LU0329678337.USD","IE00B5MMRT66.SGD","159982","LU0972618739.USD","LU2097828474.EUR","LU0345780281.USD","IE00BZ08YT58.USD","LU0072913022.USD","LU0516423091.SGD","LU0918141705.HKD","LU1813983027.USD","LU2476274720.SGD","LU0314109678.HKD","LU0886674414.USD","LU0572944931.SGD","BK1546","LU1023057109.AUD","LU2778985437.USD","BK1526","BK1202","IE0008368742.USD","LU0211977185.USD","LU0501845795.SGD","LU1807302812.USD","BK1505","BK1507","HK0000320264.USD","LU0181495838.USD","LU0264606111.USD","LU0315179316.USD","LU0345780521.USD","LU1008478684.HKD","LU1720050803.USD","LU0266512127.USD","LU0359201612.USD","BK1583","SG9999014674.SGD","IE0032431581.USD","BK1610","LU0708995583.HKD","LU0163747925.USD","LU1794554557.SGD","SG9999004220.SGD","BK1184","BK1509","LU0823426480.USD","BK1237","LU0061477393.USD","01812","LU0648948544.HKD","BK1516","LU0348825331.USD","LU1226287529.USD","LU0348735423.USD","LU2039709279.SGD","BK1148","LU0229945570.USD","LU0329678170.USD","LU2045819591.USD","BK1191","LU0509642566.USD","LU0456827905.SGD","BK1163","HK0000320223.HKD","IE0034224299.USD","LU0348827113.USD","SG9999006597.SGD","BK1550","LU1105468828.SGD","HK0000306701.USD","LU0384037296.USD","03143","LU0106252389.USD","LU0266512473.USD","BK1116","LU0516422366.SGD","LU0516422440.USD","BK1514","LU0067412154.USD","LU0593848301.USD","002703","300750","BK1147","LU0327786744.USD","LU0979878070.USD","LU1282648689.USD","LU0572940350.SGD","LU1770034418.SGD","LU0797268264.HKD","LU2097828557.USD","LU0823426308.USD","IE00BVYPNP33.GBP","LU0488056044.USD","LU1303224171.USD","BK1592","BK1501","LU0164865239.USD","LU1785774172.SGD","BK1214","BK1170","IE00B031J352.USD","LU1769817179.HKD","BK1231","LU1719994722.HKD","LU0228659784.USD","LU0359201885.HKD","LU0540923850.HKD","LU0269904917.USD","LU0516422952.EUR","LU1152091754.HKD","LU0051755006.USD","LU1769817096.USD","IE00BYV24P56.USD","SG9999012744.USD","LU1481107354.HKD","HK0000352291.HKD","LU0543330566.HKD","IE00B0169L03.USD","02691","LU1328277881.USD","IE0008369823.USD","IE0031814852.USD","BK1183","399300","01276","BK1144","IE00B29SXG58.USD","01057","HK0000165453.HKD","LU1831875114.USD","600276","BK1137","LU0117841782.USD","BK1551","LU0828238088.HKD","IE00BGHQDM52.EUR","LU2543165471.USD","LU0469268626.HKD","LU0588546209.SGD","LU0880133367.SGD","BK1171","LU1048596156.SGD","IE00BF5LJ272.USD","BK1205","LU0048580855.USD","LU0456846285.SGD","IE00BVYPNQ40.USD","LU0791591158.USD","LU2097828805.USD","LU0417516902.SGD","LU2399975544.HKD","BK1576","LU0096374516.USD","BK1544","IE00B543WZ88.USD","LU0228367735.SGD","00042","BK1558","LU0173614495.USD","LU1152091168.USD","IE00BZ08YR35.GBP","LU0737861699.HKD","LU1282649810.SGD","LU1880383366.USD","LU1282649067.USD","LU0326950275.SGD","LU0039217434.USD","LU0871576103.HKD","LU0456854461.SGD","BK1562","002202","00553","LU1675838814.USD","LU0328353924.USD","LU0828237940.HKD","IE00BMCWC346.EUR","IE00BZ08YS42.EUR","SG9999012728.SGD","LU0531971595.HKD","LU1224709979.USD","BK1594","BK1223","LU1655091616.SGD","BK1522","LU0149721374.USD"],"gpt_icon":1},{"id":"2602383553","title":"恒瑞医药获小摩增持约112.78万股 每股作价约74.61港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602383553","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602383553?lang=zh_cn&edition=full","pubTime":"2026-01-11 16:24","pubTimestamp":1768119840,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，1月6日，小摩增持恒瑞医药（01276）112.7828万股，每股作价74.6126港元，总金额约为8415.02万港元。增持后最新持股数目约为1919.4万股，最新持股比例为7.43%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-01-11/doc-inhfxmcp3824639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0183","LU0106831901.USD","LU0323591593.USD","LU2097828714.EUR","LU0070302665.USD","LU2552382132.HKD","IE00B1BXHZ80.USD","LU2430703095.HKD","LU2552382058.USD","BK0196","IE00BJLML261.HKD","IE00BBT3K403.USD","600276","01276","LU0256863811.USD","LU2237443622.USD","LU2213496289.HKD","IE000M9KFDE8.USD","LU0265550359.USD","LU2456880835.USD","LU0211328371.USD","LU0417517546.SGD","IE00BN8TJ469.HKD","LU0820561818.USD","LU1064131342.USD","LU2097828631.EUR","LU2211815571.USD","LU0238689110.USD","BK4516","LU0868494708.USD","LU2417539215.USD","LU0787776722.HKD","BK0188","LU0820561909.HKD","LU1244550577.SGD","LU2097828805.USD","LU0345769631.USD","LU0820562030.AUD","LU1668664300.SGD","IE00BHPRN162.USD","LU0251132253.USD","IE00BLSP4452.SGD","LU0203345920.USD","LU2237443549.SGD","LU2505996681.GBP","LU0320765489.SGD","LU1162221912.USD","LU2580892862.HKD","LU1894683348.USD","LU1894683264.USD"],"gpt_icon":0},{"id":"2602375349","title":"恒瑞医药：卡瑞利珠单抗在美国的BLA重新上市申报公司正在与FDA积极沟通","url":"https://stock-news.laohu8.com/highlight/detail?id=2602375349","media":"证券日报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602375349?lang=zh_cn&edition=full","pubTime":"2026-01-09 20:33","pubTimestamp":1767962029,"startTime":"0","endTime":"0","summary":"证券日报网讯1月9日，恒瑞医药在互动平台回答投资者提问时表示，卡瑞利珠单抗在美国的BLA重新上市申报公司正在与FDA积极沟通，相关事项如有进展公司将严格按照相关规定进行公告，履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601093614449751.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0405327148.USD","LU1064131003.USD","LU2488822045.USD","LU2097828805.USD","LU1655091616.SGD","LU2097828631.EUR","LU0359202008.SGD","BK0196","BK0060","LU1969619763.USD","LU2097828714.EUR","LU2495084118.USD","01276","LU1997244956.HKD","BK0012","BK1191","LU1023057109.AUD","LU2580892789.USD","LU2580892862.HKD","LU1580142542.USD","LU2097828474.EUR","LU0359201612.USD","BK0183","BK0239","LU1781817850.SGD","LU2148510915.USD","LU0405327494.USD","LU1820825898.SGD","LU2328871848.SGD","600276","LU1146622755.USD","LU1997245094.SGD","LU1997245177.USD","LU1328615791.USD","LU2543165471.USD","LU1255011170.USD","LU2097828557.USD","LU2289578879.USD","BK0028","LU1064130708.USD","BK0188","LU0359201885.HKD"],"gpt_icon":0},{"id":"2602378049","title":"恒瑞医药：公司前瞻性地广泛布局多个治疗领域，并向纵深发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2602378049","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602378049?lang=zh_cn&edition=full","pubTime":"2026-01-09 20:05","pubTimestamp":1767960346,"startTime":"0","endTime":"0","summary":"证券日报网讯1月9日，恒瑞医药在互动平台回答投资者提问时表示，公司前瞻性地广泛布局多个治疗领域，并向纵深发展。公司在肿瘤领域有丰富的研发管线，与此同时，在代谢和心血管疾病、免疫和呼吸系统疾病、神经科学等领域也进行了广泛布局，打造长期发展的多元化战略支柱。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601093614409744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2488822045.USD","LU1023057109.AUD","LU1997245177.USD","LU0359202008.SGD","LU2580892862.HKD","LU1781817850.SGD","LU2328871848.SGD","01276","LU2097828631.EUR","BK0239","LU2495084118.USD","LU2097828557.USD","LU0359201612.USD","LU0405327148.USD","BK0028","LU1997245094.SGD","BK0012","BK0060","600276","LU1064131003.USD","LU1655091616.SGD","LU2097828714.EUR","LU1969619763.USD","LU2097828474.EUR","LU2148510915.USD","BK1191","LU1328615791.USD","LU1064130708.USD","LU2543165471.USD","LU1997244956.HKD","LU0359201885.HKD","LU0405327494.USD","BK0183","LU2097828805.USD","LU2289578879.USD","LU2580892789.USD","BK0188","LU1146622755.USD","BK0196","LU1255011170.USD","LU1580142542.USD","LU1820825898.SGD"],"gpt_icon":0},{"id":"2602547378","title":"小摩增持恒瑞医药(01276)约112.78万股 每股作价约74.61港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602547378","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602547378?lang=zh_cn&edition=full","pubTime":"2026-01-09 19:29","pubTimestamp":1767958148,"startTime":"0","endTime":"0","summary":"1月6日，小摩增持恒瑞医药(01276)112.7828万股，每股作价74.6126港元，总金额约为8415.02万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260109/20260109193002_54761.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260109/20260109193002_54761.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1064131342.USD","IE00BLSP4239.USD","LU2097828805.USD","LU2357305700.SGD","LU1084165304.USD","BK4533","IE00BKVL7J92.USD","LU1244550494.USD","LU1255011170.USD","LU2237443549.SGD","IE0034235295.USD","LU0417517546.SGD","LU1328615791.USD","LU1551013342.USD","IE00BLSP4452.SGD","LU2242649171.HKD","LU1720051108.HKD","LU1668664300.SGD","LU1548497426.USD","LU0234572021.USD","LU0405327148.USD","LU1146622755.USD","LU1894683264.USD","LU0215105999.USD","LU2023250330.USD","600276","BK0196","LU0689472784.USD","LU1974910355.USD","LU1720051017.SGD","LU1145028129.USD","LU1267930490.SGD","LU2264538146.SGD","LU0256863811.USD","IE00BJTD4V19.USD","LU2756315664.SGD","IE00BDRTCR15.USD","01276","LU0971096721.USD","BK4550","LU1997244956.HKD","LU2746668461.USD","LU2580892789.USD","LU1116320737.USD","LU0640476718.USD","LU0323591593.USD","LU0820561818.USD","LU1119994496.HKD","BK0012","LU2552382215.SGD"],"gpt_icon":0},{"id":"2602429324","title":"“年度最受关注IPO公司”榜单出炉，宁德时代、地平线等领军新经济板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2602429324","media":"港股解码","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602429324?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:45","pubTimestamp":1767951913,"startTime":"0","endTime":"0","summary":"2025香港财富管理高峰论坛暨第十二届港股100强颁奖盛典正在隆重举行，各项榜单陆续揭晓。“年度最受关注IPO公司”榜单已揭晓。宁德时代（03750.HK）、美的集团（00300.HK）、恒瑞医药（01276.HK）、紫金黄金国际（02259.HK）、海天味业（03288.HK）等各领域领军企业集体入选。该榜单囊括新能源、智能制造、生物医药、新消费及人工智能等多元赛道，展现出资本市场对新经济企业的强烈关注。这些新上市企业凭借创新动能与成长潜力，正共同塑造港股市场的新格局，为投资者提供把握未来趋势的重要参考。作者|毛婷编辑|Danna","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109175936a4afd9b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109175936a4afd9b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1008478684.HKD","LU1152091754.HKD","01276","BK1610","600276","603288","LU1993786604.SGD","LU0880133367.SGD","LU0067412154.USD","03288","BK1116","LU1807302812.USD","00300","000333","300750","LU1960683339.HKD","LU1152091168.USD","02259","03750"],"gpt_icon":0},{"id":"2602326203","title":"恒瑞医药：注射用SHR-4394获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2602326203","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602326203?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:09","pubTimestamp":1767949759,"startTime":"0","endTime":"0","summary":"21智讯1月9日电，恒瑞医药公告，恒瑞医药收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意注射用SHR-4394开展临床试验。审批结论显示，该药物符合药品注册相关要求，同意开展SHR-4394或HRS-5041联合抗肿瘤治疗在前列腺癌参与者中的安全性、耐受性及有效性的多中心、开放II期临床研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601093614272360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1997245177.USD","LU2148510915.USD","LU0405327148.USD","LU0405327494.USD","BK0239","LU1580142542.USD","BK0188","LU2488822045.USD","LU1969619763.USD","BK0012","BK0028","LU2097828631.EUR","LU1023057109.AUD","BK0183","LU0359202008.SGD","LU2097828557.USD","01276","BK1191","LU1328615791.USD","LU2097828714.EUR","LU2495084118.USD","LU1820825898.SGD","LU1781817850.SGD","LU1255011170.USD","LU1655091616.SGD","LU2097828805.USD","600276","LU2328871848.SGD","BK0196","BK0060","LU1146622755.USD","LU1064130708.USD","LU1997244956.HKD","LU0359201885.HKD","LU2289578879.USD","LU2543165471.USD","LU2580892862.HKD","LU2580892789.USD","LU1064131003.USD","LU2097828474.EUR","LU0359201612.USD","LU1997245094.SGD"],"gpt_icon":0},{"id":"2602332362","title":"智通AH统计|1月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2602332362","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602332362?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:15","pubTimestamp":1767946505,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止1月9日收盘，东北电气、浙江世宝、南京熊猫电子股份分列AH溢价率前三位，溢价率分别为785.25%、448.59%、286.79%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-10.95%、-1.58%、-0.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0588546209.SGD","LU0329678170.USD","159982","LU1675838814.USD","LU1328277881.USD","LU0328353924.USD","IE00BMCWC346.EUR","BK1184","LU2399975544.HKD","IE00BYV24P56.USD","600276","00042","600036","LU0266512473.USD","LU0348827113.USD","LU0051755006.USD","LU0640798160.USD","LU1105468828.SGD","LU0164880469.USD","BK1564","LU1115378108.SGD","LU1770034418.SGD","SG9999001051.SGD","LU1655091616.SGD","03908","LU2097828631.EUR","BK1583","LU0266512127.USD","LU0106959298.USD","LU0823426308.USD","BK1202","LU0164865239.USD","IE00BGHQDM52.EUR","LU0828238088.HKD","LU0359201885.HKD","601995","LU0509642566.USD","LU0871576103.HKD","BK1116","LU1785774172.SGD","LU1366334578.USD","BK1551","BK1514","BK1147","LU1242518931.SGD","LU0345780281.USD","LU2778985437.USD","LU0370786039.SGD","300750","IE00BVYPNP33.GBP","IE00B031J352.USD","HK0000320223.HKD","IE0008368742.USD","LU0417516902.SGD","LU0823426480.USD","BK1505","LU0431992006.USD","LU0890818403.SGD","LU0163747925.USD","BK1221","002703","LU1152091168.USD","LU0862451753.SGD","LU1211504680.USD","LU1880383440.USD","BK1137","BK1516","SG9999001069.SGD","LU0314109678.HKD","LU0501845795.SGD","BK1163","BK1592","LU0106252389.USD","LU0140636845.USD","LU1008478684.HKD","SGXZ90724238.SGD","IE00B29SXG58.USD","LU0327786744.USD","LU0572944931.SGD","LU1152091754.HKD","01276","BK1191","LU0634319403.HKD","BK1610","IE0032431581.USD","LU1720050803.USD","LU0918141887.USD","LU0329678337.USD","LU1794554557.SGD","LU0516423091.SGD","LU1366334651.USD","BK1214","BK1501","LU2476274308.USD","LU0868486357.SGD","IE00BZ08YT58.USD","LU0315179316.USD","LU1303224171.USD","IE00B031HY20.USD","LU0589944569.HKD","IE00BF5LJ272.USD","LU0231483743.USD","IE00BVYPNQ40.USD","LU1961090484.USD","LU1769817096.USD","002202","BK1144","LU0117841782.USD","BK1526","LU1048596156.SGD","BK1546","LU0348735423.USD","SG9999002950.SGD","SG9999012736.USD","LU1807302812.USD","LU0516422366.SGD","BK1141","IE0008369823.USD","LU1242518857.USD","IE00B0169L03.USD","LU0918141705.HKD","BK1148","LU0828237940.HKD","LU1282648689.USD","LU2125910500.SGD","00553","LU0488056044.USD","IE0034224299.USD","IE00BZ08YS42.EUR","LU1188198961.HKD","LU0531971595.HKD","LU0593848301.USD","BK1550","LU2476274720.SGD","03968","399300","LU1481107354.HKD","LU0540923850.HKD","03750","LU0269904917.USD","LU0543330566.HKD","LU0049853897.USD","LU0516422440.USD","LU0516422952.EUR","BK1149","LU1226287529.USD","BK1560","SG9999001093.SGD","BK1584","SG9999014674.SGD","LU0229945570.USD","LU0348788117.USD","LU2242644610.SGD","LU0456827905.SGD","LU0244354667.USD","LU0828237510.HKD","BK1558","LU1813983027.USD","HK0000306701.USD","LU0039217434.USD","SG9999004220.SGD","LU0821914370.USD","LU1993786604.SGD","LU0096374516.USD","LU1046422090.SGD","LU2097828805.USD","LU0173614495.USD","IE0031814852.USD","LU0061477393.USD","LU1282649141.HKD","SG9999002828.SGD","LU0067412154.USD","LU2039709279.SGD","BK1110","BK1509","LU0561508036.HKD","600775","LU1831875114.USD","BK1237","BK1544","LU0052750758.USD","LU0516423174.USD","LU2097828557.USD","LU0359202008.SGD","000488","BK1507","BK1205","01812","HK0000306685.HKD","LU0979878070.USD","LU1880383366.USD","LU2226246903.HKD","LU0384037296.USD","BK1521","LU0648948544.HKD","BK1522","LU0469268626.HKD","LU0456854461.SGD","LU0797268264.HKD","LU0287142896.SGD","IE00BZ08YR35.GBP","LU0502904849.HKD","SG9999002463.SGD","LU1769817179.HKD","LU0791591158.USD","CIHKY","LU0228367735.SGD","LU0791590937.USD","LU0149721374.USD","BK1170","HK0000320264.USD","IE00B543WZ88.USD","LU0348816934.USD","LU2097828714.EUR","SG9999012744.USD","LU1023057109.AUD","LU0359201612.USD","LU0456846285.SGD","LU0737861699.HKD","LU0348814723.USD","LU1224709979.USD","LU1808992512.USD","LU2543165471.USD","BK1183","LU0181495838.USD","LU0972618739.USD","LU2097828474.EUR","LU0048580855.USD","SG9999006597.SGD","LU1688375341.USD","LU1282649067.USD","BK1198","LU0348805143.USD","LU0880133367.SGD","SG9999003461.SGD","BK1513","LU1504937902.USD","LU0348825331.USD","LU0417516738.SGD","HK0000165453.HKD","LU0345780521.USD","BK1565","BK1223","LU2045819591.USD","LU0211977185.USD","BK1562","BK1554","LU0708995583.HKD","LU0455707207.USD","SG9999012710.SGD","03143","BK1231","BK1594","LU0326950275.SGD","LU0228659784.USD","LU1282649810.SGD","BK1576","01057","LU0307460666.USD","LU1960683339.HKD","LU0072913022.USD","BK1171","LU0886674414.USD","IE00B3M56506.USD","LU1251922891.USD","SG9999012728.SGD","LU0320764599.SGD","LU1719994722.HKD","LU0463099449.HKD","IE00B5MMRT66.SGD","LU0737861772.HKD"],"gpt_icon":1},{"id":"2601533894","title":"宜明昂科与Axion“分手”；江西省卫健委党组书记被查","url":"https://stock-news.laohu8.com/highlight/detail?id=2601533894","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601533894?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:41","pubTimestamp":1767832919,"startTime":"0","endTime":"0","summary":"政策动向国家药监局：优化临床急需境外已上市药品审评审批央视新闻消息显示，为加快临床急需境外已上市药品在境内上市，满足患者临床用药迫切需求，国家药监局进一步优化这类药品审评审批。国家药监局表示，坚持以临床价值为导向，鼓励申请人在中国开展全球同步研发、同步申报上市；鼓励临床急需境外已上市的原研药及仿制药在境内申报，对于符合要求的可纳入优先审评审批范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601083612141760.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601083612141760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0196","BK0060","LU1655091616.SGD","LU1969619763.USD","BK0183","LU2580892862.HKD","LU2328871848.SGD","LU0405327494.USD","BK0077","LU2097828805.USD","688321","BK0028","BK0251","LU2097828557.USD","LU1328615791.USD","LU1580142542.USD","BK0114","LU2580892789.USD","LU1146622755.USD","002173","LU2488822045.USD","LU2097828714.EUR","600276","LU0405327148.USD","BK0096","LU1781817850.SGD","300653","LU1997245094.SGD","LU1997245177.USD","LU1064131003.USD","LU2097828474.EUR","BK0012","LU2097828631.EUR","LU1255011170.USD","LU1820825898.SGD","LU2148510915.USD","LU2495084118.USD","LU1997244956.HKD","BK0188","LU1064130708.USD","LU2289578879.USD","BK0236","BK0046","688759","BK0239"],"gpt_icon":0},{"id":"2601871257","title":"恒瑞医药：瑞拉芙普α注射液获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2601871257","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601871257?lang=zh_cn&edition=full","pubTime":"2026-01-07 18:24","pubTimestamp":1767781450,"startTime":"0","endTime":"0","summary":"人民财讯1月7日电，恒瑞医药(600276)1月7日公告，近日，公司子公司苏州盛迪亚生物医药有限公司收到国家药监局的通知，批准公司自主研发的1类创新药瑞拉芙普α注射液上市。该药品联合氟尿嘧啶类和铂类药物用于经充分验证的检测评估PD-L1阳性（CPS≥1）的局部晚期不可切除、复发或转移性胃及胃食管结合部腺癌的一线治疗。经查询，国内外尚无同类产品获批上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601073611587624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2148510915.USD","LU1064131003.USD","LU1969619763.USD","LU2580892862.HKD","LU2495084118.USD","BK0196","LU1023057109.AUD","LU1064130708.USD","LU2097828557.USD","BK0028","LU1255011170.USD","LU2543165471.USD","LU1146622755.USD","LU1580142542.USD","BK0183","LU1997244956.HKD","600276","LU1328615791.USD","LU2097828714.EUR","LU1997245094.SGD","LU1781817850.SGD","LU1997245177.USD","LU2488822045.USD","LU0359201885.HKD","LU2097828631.EUR","BK0012","LU0405327148.USD","BK0060","01276","BK0239","BK0188","LU2328871848.SGD","LU2580892789.USD","LU0359201612.USD","BK1191","LU2097828474.EUR","LU0359202008.SGD","LU1820825898.SGD","LU1655091616.SGD","LU0405327494.USD","LU2289578879.USD","LU2097828805.USD"],"gpt_icon":0},{"id":"2601685608","title":"恒瑞医药2025年12月股份变动：A股员工持股计划致总股本微增","url":"https://stock-news.laohu8.com/highlight/detail?id=2601685608","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601685608?lang=zh_cn&edition=full","pubTime":"2026-01-06 11:52","pubTimestamp":1767671537,"startTime":"0","endTime":"0","summary":"中访网数据 江苏恒瑞医药股份有限公司于2026年1月5日发布了截至2025年12月31日的证券变动月报表。报告显示，公司总股本在报告期内略有增加。此次A股股份的增加，源于公司根据其2022年、2023年、2024年及2025年A股员工持股计划进行的股份授予或归属，本月内因此新增发行了3,738,950股A股。本次变动后，江苏恒瑞医药的总已发行股份数达到6,637,199,874股。公司库存股份数量在本月内未发生变动，A股和H股的库存股份数均为零。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260106/31918645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU2097828474.EUR","BK0183","LU1997245177.USD","LU0359201885.HKD","BK0012","LU2097828714.EUR","LU0405327494.USD","LU2495084118.USD","LU2097828557.USD","BK0028","LU1064131003.USD","BK0239","LU2488822045.USD","LU0359202008.SGD","BK0196","BK0060","LU1997245094.SGD","LU1969619763.USD","399300","600276","LU1781817850.SGD","LU1580142542.USD","01276","BK1191","LU0359201612.USD","159982","LU2543165471.USD","LU2289578879.USD","LU1023057109.AUD","BK0188","LU1064130708.USD","LU1820825898.SGD","LU1255011170.USD","LU1997244956.HKD","LU1146622755.USD","LU2097828805.USD","LU0405327148.USD","LU2148510915.USD","LU1328615791.USD","LU2580892862.HKD","LU2328871848.SGD","LU2097828631.EUR","LU1655091616.SGD","LU2580892789.USD"],"gpt_icon":0},{"id":"2601004192","title":"恒瑞医药：子公司收到药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2601004192","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601004192?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:09","pubTimestamp":1767604169,"startTime":"0","endTime":"0","summary":"每经AI快讯，1月5日，恒瑞医药公告，恒瑞医药收到国家药品监督管理局核准签发的关于HRS-4357注射液、HRS-5041片的《药物临床试验批准通知书》，同意开展临床试验。具体为：HRS-4357联合HRS-5041用于PSMA阳性前列腺癌治疗的安全性、耐受性及初步疗效的开放、多中心、Ib/II期临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601053608869671.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601053608869671.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0028","BK0188","LU1328615791.USD","LU0405327148.USD","LU2495084118.USD","LU2488822045.USD","LU1146622755.USD","LU1969619763.USD","LU1997245094.SGD","LU2580892789.USD","LU2097828714.EUR","LU1997244956.HKD","LU0359202008.SGD","LU2543165471.USD","BK0239","LU1781817850.SGD","LU1064130708.USD","LU2148510915.USD","LU1064131003.USD","BK0196","LU2580892862.HKD","BK1191","LU1997245177.USD","LU1820825898.SGD","LU0359201612.USD","BK0183","01276","LU2097828805.USD","LU0405327494.USD","LU1655091616.SGD","LU2097828474.EUR","LU2328871848.SGD","BK0060","LU1255011170.USD","BK0012","LU1023057109.AUD","LU2097828557.USD","LU2097828631.EUR","LU2289578879.USD","600276","LU0359201885.HKD","LU1580142542.USD"],"gpt_icon":0},{"id":"2600152047","title":"恒瑞医药(01276)截至12月末累计回购A股股份889.87万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2600152047","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600152047?lang=zh_cn&edition=full","pubTime":"2026-01-04 18:48","pubTimestamp":1767523708,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药(01276)发布公告，2025年12月，公司通过上海证券交易所交易系统以集中竞价交易方式回购股份0股。截至2025年12月31日，公司本次股份回购方案累计通过上海证券交易所交易系统以集中竞价交易方式回购股份889.87万股，已回购股份占公司总股本的比例为0.13%，购买的最高价为人民币70.00元/股，最低价为人民币59.32元/股，已支付的总金额为人民币59,521.63万元(不含交易费用)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","BK0239","399300","LU0405327148.USD","LU0359201885.HKD","BK0012","LU1997245094.SGD","600276","BK0028","LU0359202008.SGD","LU1064131003.USD","LU1580142542.USD","BK0060","LU1969619763.USD","BK1191","LU2495084118.USD","BK0183","LU2097828474.EUR","LU2097828631.EUR","LU2289578879.USD","159982","LU2097828714.EUR","LU1023057109.AUD","LU2543165471.USD","LU1997245177.USD","LU1064130708.USD","LU1820825898.SGD","LU2097828805.USD","LU1255011170.USD","LU2148510915.USD","LU1655091616.SGD","LU2328871848.SGD","LU2580892789.USD","BK0188","LU1146622755.USD","LU2097828557.USD","01276","BK0196","LU1328615791.USD","LU1997244956.HKD","LU0405327494.USD","LU1781817850.SGD","LU2580892862.HKD","LU0359201612.USD"],"gpt_icon":0},{"id":"2600054319","title":"智通AH统计|1月2日","url":"https://stock-news.laohu8.com/highlight/detail?id=2600054319","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600054319?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:15","pubTimestamp":1767341704,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止1月2日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为847.37%、398.38%、286.02%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-14.50%、-5.83%、-3.71%。其中浙江世宝、广和通、中船防务的偏离值位居前三，分别为86.11%、17.07%、11.89%；另外，东北电气、新华保险、广汽集团的偏离值位居后三，分别为-40.60%、-13.42%、-13.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388139.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","LU0117841782.USD","LU0572940350.SGD","LU0828237510.HKD","BK1171","600276","LU0181495838.USD","LU0828237940.HKD","LU0871576103.HKD","LU0052750758.USD","LU0106252389.USD","LU0348814723.USD","LU1105468828.SGD","LU1152091754.HKD","BK1214","LU1366334651.USD","LU1224709979.USD","LU1675838814.USD","IE00BMCWC346.EUR","LU2476274720.SGD","LU0348816934.USD","LU1251922891.USD","HK0000306701.USD","LU2097828631.EUR","HK0000500386.USD","LU2097828474.EUR","SG9999003461.SGD","BK1592","LU0502904849.HKD","00042","LU0823040885.USD","LU0359202008.SGD","LU0572944931.SGD","LU0918141887.USD","LU1303224171.USD","BK1237","LU0918141705.HKD","LU2226246903.HKD","BK1144","LU1046422090.SGD","LU0328353924.USD","BK1509","LU0791590937.USD","LU2543165471.USD","BK1191","LU1770034418.SGD","LU0797268264.HKD","LU0228367735.SGD","BK1119","BK1583","LU1720050803.USD","LU1242518857.USD","BK1154","159982","BK1562","300750","LU0320764599.SGD","LU0516423091.SGD","BK1526","LU0737861772.HKD","LU0067412154.USD","LU1048596156.SGD","LU0456854461.SGD","LU1226287529.USD","LU1807302812.USD","LU0264606111.USD","03678","LU0315179316.USD","IE00BVYPNP33.GBP","03143","SG9999002463.SGD","LU0417516902.SGD","LU0821914370.USD","LU1152091168.USD","BK1129","LU1688375341.USD","LU1188198961.HKD","LU0469268626.HKD","BK1184","LU0048580855.USD","LU1211504680.USD","LU0640798160.USD","LU1282649810.SGD","LU0516423174.USD","LU2039709279.SGD","LU0329678170.USD","LU2778985437.USD","LU1023057109.AUD","LU1831875114.USD","LU1282649141.HKD","LU0868486357.SGD","03968","BK1550","BK1576","IE00B543WZ88.USD","HK0000252160.HKD","LU0501845795.SGD","LU1242518931.SGD","HK0000306685.HKD","LU0823426480.USD","IE00BZ08YS42.EUR","BK1116","BK1179","BK1523","IE0008369823.USD","BK1546","LU0880133367.SGD","BK1202","LU1880383440.USD","LU0431992006.USD","LU0096374516.USD","IE0034224299.USD","LU0329678337.USD","LU0348805143.USD","IE0008368742.USD","LU0589944569.HKD","LU0823426308.USD","LU0370786039.SGD","SG9999004220.SGD","LU0572939691.SGD","BK1564","IE00B0169L03.USD","BK1539","BK1231","LU0164880469.USD","LU0516422366.SGD","SG9999006597.SGD","LU2476274308.USD","LU0163747925.USD","LU0072913022.USD","LU0348827113.USD","BK1190","LU0463099449.HKD","BK1614","001236","LU0516422440.USD","LU0634319403.HKD","LU0516422952.EUR","BK1594","600036","IE00B031J352.USD","LU0648948544.HKD","LU0449515922.USD","LU2399975544.HKD","LU0049853897.USD","LU0449509016.USD","LU2045819591.USD","LU0588546209.SGD","HK0000252152.HKD","BK1105","LU1504937902.USD","01057","BK1554","LU1719994722.HKD","LU0540923850.HKD","BK1507","LU0106959298.USD","LU0314109678.HKD","LU0348825331.USD","LU0455707207.USD","BK1173","BK1522","LU0531970944.HKD","LU0307460666.USD","LU0593848301.USD","LU0862451753.SGD","BK1223","LU1282649067.USD","LU1366334578.USD","LU1769817096.USD","LU0244354667.USD","BK1610","LU2097828805.USD","LU0348735423.USD","002703","399300","LU0417516738.SGD","LU2097828557.USD","LU0054450605.USD","LU0231483743.USD","LU1961090484.USD","LU1880383366.USD","LU0149721374.USD","LU0348788117.USD","LU0737861699.HKD","LU0327786744.USD","LU1813983027.USD","LU1993786604.SGD","LU0890818403.SGD","LU0173614495.USD","LU0228659784.USD","LU0266512127.USD","BK1141","LU0287142896.SGD","LU0979878070.USD","BK1607","LU1769817179.HKD","IE00B031HY20.USD","LU0886674414.USD","LU0543330566.HKD","LU0345780521.USD","IE00BZ08YT58.USD","LU0254981946.USD","IE00BGHQDM52.EUR","HK0000320223.HKD","LU0051755006.USD","LU0164865239.USD","BK1183","CIHKY","BK1584","LU0345780281.USD","LU0456827905.SGD","LU0708995583.HKD","LU1282648689.USD","LU2097828714.EUR","LU0531971595.HKD","IE0031814852.USD","BK1544","LU0140636845.USD","BK1198","SG9999014674.SGD","LU1115378108.SGD","LU0211977185.USD","BK1514","IE00BVYPNQ40.USD","BK1551","BK1560","IE00B3M56506.USD","IE00BF5LJ272.USD","LU1481107354.HKD","LU1328277881.USD","LU1960683339.HKD","LU2242644610.SGD","LU0456846285.SGD","BK1205","BK1506","LU1794554557.SGD","LU1808992512.USD","LU0214875030.USD","BK1521","LU0359201612.USD","LU0359201885.HKD","LU0791591158.USD","01276","HK0000320264.USD","BK1515","BK1147","LU2125910500.SGD","BK1124","BK1535","IE00BZ08YR35.GBP","LU0326950275.SGD","LU0061477393.USD","SG9999002828.SGD","BK1505","LU0229945570.USD","LU0266512473.USD","LU0488056044.USD","IE00BYV24P56.USD","LU0039217434.USD","LU1008478684.HKD","IE00B29SXG58.USD","BK1149","SG9999001226.SGD","LU0561508036.HKD","BK1558","LU0384037296.USD","BK1163"],"gpt_icon":1},{"id":"2600056352","title":"港股异动 | 恒瑞医药(01276)午后涨超5% CLDN18.2 ADC胃癌适应症纳入突破性治疗品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2600056352","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600056352?lang=zh_cn&edition=full","pubTime":"2026-01-02 13:43","pubTimestamp":1767332632,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，恒瑞医药午后涨超5%，截至发稿，涨5.19%，报74.95港元，成交额5568.71万港元。消息面上，恒瑞医药宣布，其自主研发的靶向Claudin18.2的抗体药物偶联物——注射用SHR-A1904，已被国家药品监督管理局药品审评中心正式纳入突破性治疗品种名单。该药物拟用于治疗既往接受过至少一线系统治疗的CLDN18.2阳性的局部晚期或转移性胃或胃食管交界处腺癌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0188","LU1328615791.USD","LU0405327148.USD","LU2495084118.USD","BK4231","LU2488822045.USD","LU1146622755.USD","LU1969619763.USD","LU1997245094.SGD","LU2580892789.USD","LU2097828714.EUR","LU1997244956.HKD","LU0359202008.SGD","BK4080","LU2543165471.USD","ADC","BK0239","LU1781817850.SGD","LU1064130708.USD","LU2148510915.USD","LU1064131003.USD","BK0196","LU2580892862.HKD","BK1191","LU1997245177.USD","LU1820825898.SGD","LU0359201612.USD","BK0183","01276","LU2097828805.USD","LU0405327494.USD","LU1655091616.SGD","LU2097828474.EUR","LU2328871848.SGD","BK0060","LU1255011170.USD","BK0012","LU1023057109.AUD","LU2097828557.USD","LU2097828631.EUR","LU2289578879.USD","600276","LU0359201885.HKD","LU1580142542.USD"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768432217319,"stockEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0363},{"period":"3month","weight":-0.0483},{"period":"6month","weight":0.0825},{"period":"1year","weight":0.4414},{"period":"ytd","weight":0.0678}],"compareEarnings":[{"period":"1week","weight":0.0099},{"period":"1month","weight":0.0667},{"period":"3month","weight":0.0536},{"period":"6month","weight":0.1674},{"period":"1year","weight":0.2731},{"period":"ytd","weight":0.0396}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏恒瑞医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"397246人(较上一季度增加8.94%)","perCapita":"16058股","listingDate":"2000-10-18","address":"江苏省连云港市连云区经济技术开发区黄河路38号","registeredCapital":"663719万元","survey":"　　江苏恒瑞医药股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是硫培非格司亭注射液、马来酸吡咯替尼片、注射用卡瑞利珠单抗、瑞维鲁胺片、海曲泊帕乙醇胺片、碘佛醇注射液。","listedPrice":11.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"恒瑞医药(600276)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供恒瑞医药(600276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"恒瑞医药,600276,恒瑞医药股票,恒瑞医药股票老虎,恒瑞医药股票老虎国际,恒瑞医药行情,恒瑞医药股票行情,恒瑞医药股价,恒瑞医药股市,恒瑞医药股票价格,恒瑞医药股票交易,恒瑞医药股票购买,恒瑞医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"恒瑞医药(600276)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供恒瑞医药(600276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}